David Baker

Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy

Lee T. Bacheler, Elizabeth D. Anton, Phil Kudish et al. · Antimicrobial Agents and Chemotherapy · 2000 · 270 citations · Full text

Human Retrovirus, Immunodeficiencies, Mutations Selected +14

Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

Lee T. Bacheler, Susan Jeffrey, George J. Hanna et al. · Journal of Virology · 2001 · 238 citations · Full text

Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial

Allison Martin, Mark Bloch, Janaki Amin et al. · Clinical Infectious Diseases · 2009 · 222 citations · Full text

Atomic layer deposition of tin oxide films using tetrakis(dimethylamino) tin

Jeffrey W. Elam, David Baker, Alexander J. Hryn et al. · Journal of Vacuum Science & Technology A Vacuum Surfaces and Films · 2008 · 190 citations

Materials Science, Sno2 Films, Engineering +13

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck

Katarina M. Braun, Gage K. Moreno, Peter Halfmann et al. · PLoS Pathogens · 2021 · 123 citations · Full text

Domestic Cats, Narrow Bottleneck, Viral Evolution +12